Oncolytics Biotech Inc T.ONC

Drum beat until May 25th

[SundayMovies]

I liked what heard at the conference call.

Next Tuesday is the annual shareholders meeting. 
We get more (new) suprise news then again.

Today we learned how close they are to a CAR-T cell deal (potentail partner replicating their trial)...

The drums are beating, the momentum is set upward until May 25th. This stock is an easy trade if you want to make a quick buck per share.

The data is overwhelming positive as management is building expectation even higher with KOL organised for breast... 

Easy money.

[jimsenior]

@SundayMovies. I found some valuable info at the following search.  Studies Test CAR-T Cell Therapies Designed to Overcome Key Limitations.

[jimsenior]

It has been suggested that mBC may be going forward without a CPI. As the science guys have not responded to this, I have decided to look at the situation from my lay perspective.   In no particular order: 1. mBC. Phase 3 Bridging Study in Chinese patients, Not Recruiting. An oral ASCO Poster that is most promising. The possibility of AA. with Pela plus Paclitaxel. 2. Multiple Myeloma

[jimsenior]

Spelling correction. Tecentriq.

[askretka]

Jimsenior That's a pretty good summary actually.  The big thing you missed was that a company with their own CAR-T has reproduced the original 7/7 mouse cures or close to it. Results are " IN LINE " with those reported in Translational Medicine article. They are now repeating the results just to be sure. Because CAR-T's are gene specific and each one is a bit different